I C U Medical Inc (ICUI)

$175.10 0.00 (N/A)
Market Cap 4.38B
Revenue (ttm) 2.23B
Net Income (ttm) 730,000.00
EPS (ttm) N/A
PE Ratio 26.13
Forward PE 24.34
Profit Margin 0.03%
Debt to Equity Ratio 0.57
Volume 162,200
Avg Vol 310,882
Day's Range N/A - N/A
Shares Out 24.99M
Stochastic %K 7%
Beta 0.74
Analysts Strong Sell
Price Target $195.57

Company Profile

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for port...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 949 366 2183
Fax: 949 366 8368
Address:
951 Calle Amanecer, San Clemente, United States
Estimize
Estimize Aug. 24 at 1:03 PM
Wall St is expecting 2.14 EPS for $ICUI Q3 [Reporting 11/09 AMC] http://www.estimize.com/intro/icui?chart=historical&metric_name=eps&utm_co
0 · Reply
Trendrebel
Trendrebel Aug. 15 at 9:41 AM
$ICUI I would like to play this gap fill. Not a lot of percentages, but still free money.
0 · Reply
Noname2022
Noname2022 Aug. 13 at 12:41 PM
$CRMD $ICUI Study with Clearguard HD caps & Defencath results later this year!
0 · Reply
EarningsInsider
EarningsInsider Aug. 6 at 9:32 PM
https://www.marketbeat.com/earnings/reports/2026-8-6-icu-medical-inc-stock/ $ICUI ICU Medical Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 6 at 8:18 PM
$ICUI Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.76 down -46.85% YoY • Reported revenue of $551.68M up 0.51% YoY • For Fiscal Year 2026, ICU Medical, Inc. is updating its estimates of GAAP net income to a range of $73 million to $83 million and Adjusted EBITDA to $415 million to $435 million.
0 · Reply
Estimize
Estimize Aug. 6 at 3:01 PM
$ICUI reports after the close, Estimize Consensus +0.10 EPS and +2.33M Revs compared to WS http://www.estimize.com/icui/fq2-2026?utm_conten
0 · Reply
Noname2022
Noname2022 Aug. 2 at 1:06 PM
$CRMD $ICUI $DVA $FMS Clearguard HD: guessing DVA contract & best guess at access trends based on their marketing data (Fresenius uses both Clearguard HD & Defencath!) On the Q2 2024 call, ICU Medical said it had: “recently signed a multi-year committed agreement with a leading U.S. operator of dialysis clinics” Management said the agreement would expand its evidence base and help attract other dialysis operators. https://stockanalysis.com/stocks/icui/transcripts/192237-q2-2024/
0 · Reply
Noname2022
Noname2022 Jul. 27 at 7:52 PM
$CRMD $DVA $FMS $ICUI The actual poster of Clearguard HD being implemented at Davita system wide in 2019 note 34% reduction system wide… https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3442083
1 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Jun. 23 at 4:32 PM
$ICUI Golden cross set up
0 · Reply
Noname2022
Noname2022 Jun. 4 at 11:29 PM
$CRMD $ICUI $DVA $FMS Hidden gem from ACCP 2025. CorMedix tested DefenCath’s taurolidine alongside a chlorhexidine catheter cap and found no antagonism across 46 isolates, with additive activity observed in ~70%. All tested S. aureus, K. pneumoniae, and P. aeruginosa isolates showed additivity. Not every poster is about efficacy. Some are about removing barriers to adoption. This one appears to do exactly that. https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70148
1 · Reply
Latest News on ICUI
No data available.
Estimize
Estimize Aug. 24 at 1:03 PM
Wall St is expecting 2.14 EPS for $ICUI Q3 [Reporting 11/09 AMC] http://www.estimize.com/intro/icui?chart=historical&metric_name=eps&utm_co
0 · Reply
Trendrebel
Trendrebel Aug. 15 at 9:41 AM
$ICUI I would like to play this gap fill. Not a lot of percentages, but still free money.
0 · Reply
Noname2022
Noname2022 Aug. 13 at 12:41 PM
$CRMD $ICUI Study with Clearguard HD caps & Defencath results later this year!
0 · Reply
EarningsInsider
EarningsInsider Aug. 6 at 9:32 PM
https://www.marketbeat.com/earnings/reports/2026-8-6-icu-medical-inc-stock/ $ICUI ICU Medical Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 6 at 8:18 PM
$ICUI Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.76 down -46.85% YoY • Reported revenue of $551.68M up 0.51% YoY • For Fiscal Year 2026, ICU Medical, Inc. is updating its estimates of GAAP net income to a range of $73 million to $83 million and Adjusted EBITDA to $415 million to $435 million.
0 · Reply
Estimize
Estimize Aug. 6 at 3:01 PM
$ICUI reports after the close, Estimize Consensus +0.10 EPS and +2.33M Revs compared to WS http://www.estimize.com/icui/fq2-2026?utm_conten
0 · Reply
Noname2022
Noname2022 Aug. 2 at 1:06 PM
$CRMD $ICUI $DVA $FMS Clearguard HD: guessing DVA contract & best guess at access trends based on their marketing data (Fresenius uses both Clearguard HD & Defencath!) On the Q2 2024 call, ICU Medical said it had: “recently signed a multi-year committed agreement with a leading U.S. operator of dialysis clinics” Management said the agreement would expand its evidence base and help attract other dialysis operators. https://stockanalysis.com/stocks/icui/transcripts/192237-q2-2024/
0 · Reply
Noname2022
Noname2022 Jul. 27 at 7:52 PM
$CRMD $DVA $FMS $ICUI The actual poster of Clearguard HD being implemented at Davita system wide in 2019 note 34% reduction system wide… https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3442083
1 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Jun. 23 at 4:32 PM
$ICUI Golden cross set up
0 · Reply
Noname2022
Noname2022 Jun. 4 at 11:29 PM
$CRMD $ICUI $DVA $FMS Hidden gem from ACCP 2025. CorMedix tested DefenCath’s taurolidine alongside a chlorhexidine catheter cap and found no antagonism across 46 isolates, with additive activity observed in ~70%. All tested S. aureus, K. pneumoniae, and P. aeruginosa isolates showed additivity. Not every poster is about efficacy. Some are about removing barriers to adoption. This one appears to do exactly that. https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70148
1 · Reply
NVDAMillionaire
NVDAMillionaire May. 19 at 6:17 PM
$ICUI Brilliant piece that captures ICUI's situation perfectly. So if you want to update your understanding of ICUI or get to know ICUI better, this is essential reading. https://everyticker.com/quote/ICUI/analysis/icu-medical-s-margin-renaissance-how-portfolio-surgery-and-pump-innovation-are-reshaping-the-infusion-therapy-leader-nasdaq-icui
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice May. 13 at 5:49 PM
$ICUI Medical device stocks are dead $$ All of which soon to break their 5 year lows
0 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 5:19 PM
$ICUI Current Stock Price: $124.98 Contracts to trade: $125.0 ICUI May 15 2026 Call Entry: $2.50 Exit: $4.57 ROI: 83% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 8:21 PM
$ICUI Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $1.22 up 293.65% YoY • Reported revenue of $530.23M down -12.32% YoY
0 · Reply
Noname2022
Noname2022 Apr. 30 at 12:39 AM
$CRMD $DVA $FMS $ICUI
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Apr. 29 at 4:14 PM
$ICUI Only going to get worse This sector is dead $$ for many years to come there’s no growth Only thing that can save them is M&A
0 · Reply
Noname2022
Noname2022 Apr. 29 at 2:03 PM
$CRMD $ICUI Clearguard HD presentation about implementing in an inpatient setting IMHO, Defencath superior to Clearguard HD but good to know what the other side is saying… https://player.vimeo.com/video/1002871632?badge=0&byline=0&portrait=0&title=0
1 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Apr. 28 at 5:11 PM
$ICUI These med device stocks are dead $$…
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 27 at 12:59 PM
$ICUI Share Price: $124.89 Contract Selected: Nov 20, 2026 $130 Calls Buy Zone: $15.41 – $19.04 Target Zone: $29.33 – $35.85 Potential Upside: 80% ROI Time to Expiration: 206 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Gencooliveoil
Gencooliveoil Apr. 24 at 5:06 PM
$CRMD $ICUI
0 · Reply
Noname2022
Noname2022 Apr. 24 at 1:24 PM
$CRMD $ICUI ***draft gudeline update*** On page 275; DefenCath mentioned for use in high infection risk population… couldn’t find any mention of Clearguard HD https://kdigo.org/wp-content/uploads/2026/03/KDIGO-2026-AKI-AKD-Guideline-Public-Review-Draft-March-2026.pdf
0 · Reply
Noname2022
Noname2022 Apr. 22 at 12:07 AM
$CRMD $DVA $FMS $ICUI Davita…only place without Defencath…tick tock
0 · Reply